Financial Ratios

IOL CHEMICALS AND PHARMACEUTICALS LTD.

NSE : IOLCPBSE : 524164ISIN CODE : INE485C01011Industry : Pharmaceuticals & DrugsHouse : Trident
BSE399.05-2.25 (-0.56 %)
PREV CLOSE ( ) 401.30
OPEN PRICE ( ) 403.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 7824
TODAY'S LOW / HIGH ( )398.00 404.40
52 WK LOW / HIGH ( )350.3 535.6
NSE400.35-1.6 (-0.4 %)
PREV CLOSE( ) 401.95
OPEN PRICE ( ) 401.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 400.35 (1616)
VOLUME 142518
TODAY'S LOW / HIGH( ) 393.10 404.65
52 WK LOW / HIGH ( )350.55 535.9
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)23.8428.2275.7263.5141.61
   CEPS(Rs)31.7035.5982.3569.7947.31
   DPS(Rs)4.004.006.003.000.00
   Book NAV/Share(Rs)256.61236.80214.69141.3681.74
   Tax Rate(%)26.1325.6622.2032.2529.59
Margin Ratios
   Core EBITDA Margin(%)10.2211.7330.0930.2924.31
   EBIT Margin(%)9.2910.5829.3529.2523.00
   Pre Tax Margin(%)8.5510.2029.0528.1519.95
   PAT Margin (%)6.317.5922.6019.0714.04
   Cash Profit Margin (%)8.399.5724.5820.9615.97
Performance Ratios
   ROA(%)6.858.7828.6930.6625.50
   ROE(%)9.6612.5043.0656.9369.54
   ROCE(%)13.6417.1654.2068.0955.53
   Asset Turnover(x)1.081.161.271.611.82
   Sales/Fixed Asset(x)2.523.033.093.453.48
   Working Capital/Sales(x)4.793.862.734.807.41
Efficiency Ratios
   Fixed Capital/Sales(x)0.400.330.320.290.29
   Receivable days80.2664.3553.1445.4337.39
   Inventory Days60.5358.9144.7836.2642.92
   Payable days85.3575.3169.3751.5248.43
Valuation Parameters
   PER(x)11.8712.547.272.774.57
   PCE(x)8.929.946.692.524.02
   Price/Book(x)1.101.492.561.252.33
   Yield(%)1.411.131.091.700.00
   EV/Net Sales(x)0.780.911.460.480.79
   EV/Core EBITDA(x)6.826.874.651.533.18
   EV/EBIT(x)8.358.584.971.633.45
   EV/CE(x)0.830.981.640.671.32
   M Cap / Sales0.750.951.640.530.64
Growth Ratio
   Net Sales Growth(%)1.5211.033.8312.4171.40
   Core EBITDA Growth(%)-12.57-53.214.4540.45233.72
   EBIT Growth(%)-10.89-59.964.1642.99305.20
   PAT Growth(%)-15.50-62.7423.0552.64754.51
   EPS Growth(%)-15.50-62.7419.2352.64744.31
Financial Stability Ratios
   Total Debt/Equity(x)0.050.030.000.070.61
   Current Ratio(x)1.921.982.661.871.70
   Quick Ratio(x)1.271.271.981.461.12
   Interest Cover(x)12.5127.8899.0126.487.54
   Total Debt/Mcap(x)0.050.020.000.060.27

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.